July 21st, 2023

Mirati Therapeutics, Inc. (Nasdaq: MRTX) faced a setback when the European Medicine Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a negative opinion on the Conditional Marketing Authorisation Application (MAA) for its dr. Read more

July 21st, 2023

Shares of Digital World Acquisition Corp. (Nasdaq: DWAC) surged more than 15% after settling fraud charges with the SEC. The charges were related to material misrepresentations made in forms filed during DWAC's initial public offering and its planned. Read more

July 21st, 2023

Evertec, Inc. (NYSE: EVTC) and Sinqia have entered a definitive agreement for Evertec's acquisition of Sinqia, a prominent player in Brazil's financial services software market. The deal is set at a value of R$27.19 per share, with a potential daily . Read more

July 20th, 2023

According to a regulatory filing with the SEC, Evelo Biosciences, Inc. (Nasdaq: EVLO) has entered into a Sublease Termination and Surrender Agreement with Bio-Rad Laboratories, Inc. (NYSE: BIO). The agreement terminates the Sublease, which provided E. Read more

July 20th, 2023

FOR IMMEDIATE RELEASE 2023-135 Washington D.C. / CRWE PRESS RELEASE / July 20, 2023 -  The Securities and Exchange Commission today announced settled fraud charges against Digital World Acquisition Corporation (DWAC), a special purpose . Read more

July 20th, 2023

Pasithea Therapeutics Corp. (Nasdaq: KTTA) has authorized a $4.0 million share repurchase plan (through a tender offer), to buy approximately 5.7 million shares of its outstanding common stock at $0.70 per share. The company's executive officers a. Read more

July 20th, 2023

The United States and the Arab League successfully concluded talks in Washington, D.C., addressing critical issues including regional conflicts, climate change, women’s economic empowerment, and counterterrorism. The two parties reaffirmed thei. Read more

July 20th, 2023

Genuine Parts Company (NYSE: GPC) surpassed earnings expectations in the second quarter of 2023, reporting adjusted earnings per share (EPS) of $2.44 compared to the consensus estimate of $2.34. However, quarterly sales fell short of expectations, to. Read more

July 20th, 2023

On Thursday, July 20, three prominent companies are set to unveil their financial results: Johnson & Johnson (NYSE: JNJ), a leading pharmaceutical and consumer goods company, will announce its second-quarter 2023 results before the market opens.&n. Read more

July 20th, 2023

Tesla, Inc. (Nasdaq: TSLA) has released its second-quarter 2023 financial results, surpassing earnings expectations with an adjusted EPS of $0.91 compared to the consensus estimate of $0.82. The company's quarterly revenues surged 47% year-over-year . Read more